CLINICAL PROFILE OF MOTHER WITH HUMAN IMMUNODEFICIENCY VIRUS AND ITS FETOMATERNAL OUTCOME

Authors

  • HETAXI A CHHETA Department of Obstetrics and Gynecology, C.U. Shah Medical College and Hospital, Surendranagar, Gujarat, India. https://orcid.org/0009-0005-8662-6358
  • HARSHDEEP K JADEJA Department of Obstetrics and Gynecology, C.U. Shah Medical College and Hospital, Surendranagar, Gujarat, India.
  • BHAVESH B AIRAO Department of Obstetrics and Gynecology, C.U. Shah Medical College and Hospital, Surendranagar, Gujarat, India.

DOI:

https://doi.org/10.22159/ajpcr.2025v18i5.54234

Keywords:

Human immunodeficiency virus in pregnancy,, Antiretroviral therapy, Mother-to-child transmission, Fetomaternal outcomes

Abstract

Objectives: Human immunodeficiency virus (HIV) infection carries many high-risk conditions in pregnancy. Our study aims to analyze the clinical profile of HIV-pregnant women and to determine the fetomaternal outcomes among HIV-positive pregnancies.

Methods: This study is a retrospective observational study carried out at C U Shah Medical College and Hospital, Surendranagar, Gujarat, covering data of all pregnant women with HIV who delivered between January 2018 and December 2022.

Results: Among a total of 8881 patients delivered from January 2018 to December 2022, 56 mothers with HIV positivity gave birth. 80% of HIV-positive mothers are between 21 and 30 years of age group. Among all HIV-positive pregnant patients, 30% were diagnosed during pregnancy, and 75% were taking regular antenatal care (ANC) visits. A total of 60% of HIV-positive patients were undergone vaginal delivery, and 40% underwent lower segment cesarean section. Among all HIV-positive pregnant patients, different maternal complications were found in 65% of the population. A total of 1.8% of babies are positive with HIV at 6-week postpartum intervals through mother-to-child transmission (MTCT).

Discussion: The study analyzed the 5-year clinical profile of HIV-positive mothers and their fetomaternal outcomes. The findings from the study reveal important facets related to maternal health and neonatal outcomes, the impact of antiretroviral therapy (ART), and the prevention of MTCT of HIV.

Conclusion: This study brings out the clinical profile and fetomaternal outcomes of HIV-positive mothers over 5 years, with a special emphasis on the role of ANC and ART in improving outcomes. Early diagnosis of HIV infection, regular ANC, and strict adherence to ART reduce complications and improve outcomes.

Downloads

Download data is not yet available.

References

Flower MG, Qin M, Fiscus SA, et al. Promising strategies for preventing mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2016;73(5):S210-5. 2. Townsend CL, Cortina-Borja M, Peckham CS, De Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS. 2008;22(8):973-81. doi: 10.1097/ QAD.0b013e3282f9b67a, PMID 18453857

European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40(3):458-65.

Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29(5):484-94. doi: 10.1097/00126334-200204150-00009, PMID 11981365

Marazzi MC, Nielsen-Saines K, Buonomo E, Scarcella P, Germano P, Majid NA, et al. Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-Saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding. Pediatr Infect Dis J. 2009;28(6):483-7. doi: 10.1097/INF.0b013e3181950c56, PMID 19483516

UNAIDS. Global HIV and AIDS Statistics-Fact Sheet. Switzerland: UNAIDS; 2022.

Paul V, et al. HIV in pregnancy: Current challenges. Int J Obstet Gynecol. 2021; .

Marazzi MC, et al. Mother-to-child transmission of HIV in the era of Haart: A review. J Matern Fetal Neonatal Med. 2020; .

Asif N, et al. Impact of anemia on pregnancy outcomes in HIV-infected women. BMC Pregnancy Childbirth. 2019; .

Patel S, et al. Preterm delivery in HIV-positive women: A meta- analysis. J Perinat Med. 2022;

World Health Organization. HIV and Pregnancy: Prevention of Mother- To-Child Transmission. Switzerland: WHO Guidelines; 2021.

Ekouévi DK, et al. Mother-to-child HIV transmission in sub-Saharan Africa. J Aids Res Ther. 2022;19(1):1-12.

Kourtis AP, et al. Effects of antiretroviral therapy on preterm birth and low birth weight. J Infect Dis. 2019;219(7):1098-107.

Govind A, et al. Barriers to accessing ANC among HIV-positive women. Public Health Rev. 2020;41(1):1-10.

Published

07-05-2025

How to Cite

HETAXI A CHHETA, et al. “CLINICAL PROFILE OF MOTHER WITH HUMAN IMMUNODEFICIENCY VIRUS AND ITS FETOMATERNAL OUTCOME”. Asian Journal of Pharmaceutical and Clinical Research, vol. 18, no. 5, May 2025, pp. 142-5, doi:10.22159/ajpcr.2025v18i5.54234.

Issue

Section

Original Article(s)